NASDAQ:VKTX

Viking Therapeutics Stock News

etoro logo Buy VKTX
*Your capital is at risk
$32.37
+1.99 (+6.55%)
At Close: Jun 22, 2026
Undervalued biotech stocks will always be relevant for the savvy investor. The biotech world is evolving rapidly, with pharmaceutical giants tirelessly building on their pipelines and technologies.

Is Viking Therapeutics a Millionaire-Maker?

05:50am, Friday, 19'th Jul 2024
Viking Therapeutics has a promising pipeline featuring several experimental drugs. The indications the company is targeting represent huge potential markets.
Viking Therapeutics, Inc. (VKTX) reachead $50.12 at the closing of the latest trading day, reflecting a +0.56% change compared to its last close.
The biotech sector possesses a significant predicted Compounding Annual Growth Rate (CAGR) of 14% between 2023 to 2032.  But the risks certainly match the rewards.
Conference Call Scheduled for Wednesday, July 24 at 4:30 p.m. Eastern Time SAN DIEGO , July 17, 2024 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceu
Viking Therapeutics' shares have skyrocketed this year. The biotech owes its performance to its two leading assets.
There's always a strong case for undervalued biotech stocks. For one, the industry is only expected to grow.
Viking's share price has been tumbling in recent months, and trading volumes are also down significantly. The stock could see an uptick in volume later this month once it posts its latest earnings num
GLP-1 medicines for obesity are all the rage these days. Viking Therapeutics' candidate has the edge in the speed of weight loss.
Eli Lilly and Novo Nordisk dominate a weight loss drug sector heading towards a competitive race, but the market opportunity could reach over $100 billion. Viking Therapeutics, Inc. shows promising re
Investing requires patience and a long time horizon to generate sizable profits. It's no secret that the most successful investors are people such as Warren Buffett, who are infinitely patient and hol

Forget Eli Lilly: 3 Biotech Stocks to Buy Instead

05:50am, Thursday, 04'th Jul 2024
Amgen is much cheaper than Eli Lilly. Vertex Pharmaceuticals has several major growth drivers.
Despite having no marketed drugs, Viking's (VKTX) stock continues to experience robust price movement, driven by the company's encouraging progress with its pipeline.
Viking Therapeutics stock is flying high thanks to its two leading pipeline candidates. But the biotech doesn't have any expected major catalysts to jolt its price by year-end.
With global obesity numbers bursting at the seams, some of the smartest biotech stocks to buy are those with weight loss drugs. Just look at Eli Lilly (NYSE: LLY ).
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE